These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
248 related articles for article (PubMed ID: 8943044)
21. Anti-OX40L monoclonal antibody prolongs secondary heart allograft survival based on CD40/CD40L and LFA-1/ICAM-1 blockade. Dai H; Peng F; Lin M; Xia J; Yu S; Lan G; Wang Y; Xie X; Fang C; Corbascio M; Qi Z; Peng L Transpl Immunol; 2015 Mar; 32(2):84-91. PubMed ID: 25613092 [TBL] [Abstract][Full Text] [Related]
22. [Costimulatory molecule expression on allergen-stimulated PBMC in cedar pollinosis subjects]. Morikawa H; Baba K Nihon Jibiinkoka Gakkai Kaiho; 2001 Mar; 104(3):198-207. PubMed ID: 11305050 [TBL] [Abstract][Full Text] [Related]
23. Analysis of costimulation by 4-1BBL, CD40L, and B7 in graft rejection by gene expression profiles. DeFina R; Christopher K; He H; Mandelbrot D; Gu Y; Finn P; Perkins DL J Mol Med (Berl); 2003 Oct; 81(10):655-63. PubMed ID: 12937898 [TBL] [Abstract][Full Text] [Related]
24. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. Guillonneau C; Louvet C; Renaudin K; Heslan JM; Heslan M; Tesson L; Vignes C; Guillot C; Choi Y; Turka LA; Cuturi MC; Anegon I; Josien R J Immunol; 2004 Feb; 172(3):1619-29. PubMed ID: 14734743 [TBL] [Abstract][Full Text] [Related]
25. Decreased inducible expression of CD80 and CD86 in human monocytes after ultraviolet-B irradiation: its involvement in inactivation of allogenecity. Fujihara M; Takahashi TA; Azuma M; Ogiso C; Maekawa TL; Yagita H; Okumura K; Sekiguchi S Blood; 1996 Mar; 87(6):2386-93. PubMed ID: 8630402 [TBL] [Abstract][Full Text] [Related]
27. Donor antigen is necessary for the prevention of chronic rejection in CTLA4Ig-treated murine cardiac allograft recipients. Sayegh MH; Zheng XG; Magee C; Hancock WW; Turka LA Transplantation; 1997 Dec; 64(12):1646-50. PubMed ID: 9422396 [TBL] [Abstract][Full Text] [Related]
28. Distinct requirements for host CD80/CD86 costimulatory molecules in cardiac versus islet rejection. Johnson Z; Beilke J; Pietra B; Kelly B; Gill RG Transplant Proc; 2004 May; 36(4):1171-2. PubMed ID: 15194405 [TBL] [Abstract][Full Text] [Related]
29. NK cells are required for costimulatory blockade induced tolerance to vascularized allografts. van der Touw W; Burrell B; Lal G; Bromberg JS Transplantation; 2012 Sep; 94(6):575-84. PubMed ID: 22914174 [TBL] [Abstract][Full Text] [Related]
30. The role of CD154-CD40 versus CD28-B7 costimulatory pathways in regulating allogeneic Th1 and Th2 responses in vivo. Kishimoto K; Dong VM; Issazadeh S; Fedoseyeva EV; Waaga AM; Yamada A; Sho M; Benichou G; Auchincloss H; Grusby MJ; Khoury SJ; Sayegh MH J Clin Invest; 2000 Jul; 106(1):63-72. PubMed ID: 10880049 [TBL] [Abstract][Full Text] [Related]
31. Expression of B7 molecules in recipient, not donor, mice determines the survival of cardiac allografts. Mandelbrot DA; Furukawa Y; McAdam AJ; Alexander SI; Libby P; Mitchell RN; Sharpe AH J Immunol; 1999 Oct; 163(7):3753-7. PubMed ID: 10490971 [TBL] [Abstract][Full Text] [Related]
32. The role of B7 ligands (CD80 and CD86) in CD152-mediated allograft tolerance: a crosscheck hypothesis. Tsai MK; Ho HN; Chien HF; Ou-Yang P; Lee CJ; Lee PH Transplantation; 2004 Jan; 77(1):48-54. PubMed ID: 14724434 [TBL] [Abstract][Full Text] [Related]
33. Analysis of intragraft gene and protein expression of the costimulatory molecules, CD80, CD86 and CD154, in orthotopic liver transplant recipients. Bartlett AS; McCall JL; Ameratunga R; Yeong ML; Gane E; Munn SR Am J Transplant; 2003 Nov; 3(11):1363-8. PubMed ID: 14525596 [TBL] [Abstract][Full Text] [Related]
34. Endothelial cells modify the costimulatory capacity of transmigrating leukocytes and promote CD28-mediated CD4(+) T cell alloactivation. Denton MD; Geehan CS; Alexander SI; Sayegh MH; Briscoe DM J Exp Med; 1999 Aug; 190(4):555-66. PubMed ID: 10449526 [TBL] [Abstract][Full Text] [Related]